Bladder Cancer is a gold open access journal as of January 2023. This means that every article, from the time it is first posted as a pre-press article to when it is included as part of an online volume, is immediately, permanently, and openly available for readers to view, download, share, and reuse. All articles published prior to 2023 are now available as open access under a CC license.
Authors are required to pay an open access fee of US$500 / €500 to publish under the CC BY-NC 4.0 license on acceptance for publication.
Publishing under the CC BY 4.0 license is available at US$750 / €750 (ex. VAT if applicable).
Authors who anticipate difficulties paying the open access fee may appeal to the Editors-in-Chief to discuss waiving the charge. Waivers are also available for corresponding authors from eligible countries as identified by the Research4Life project. A fee waiver may also be available if your institution has a transformative agreement with IOS Press.
PubMed Central™ deposits
This journal deposits open access articles in PubMed Central (PMC) as part of the IOS Press Open Library but can only do so if the article received NIH funding, or if any of the authors are affiliated with NIH, or associated with US Federal agency or private or international partners. Please refer the NIH Public Access Policy for the full list of participating funders and other details.